This page has been archived.
Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.
Just a few days ago, the United Kingdom notified the World Health Organization of a case of acute respiratory syndrome with renal failure. This person had a travel history to the Kingdom of Saudi Arabia and Qatar. This patient was a normally healthy 49 year-old Qatari national man, who started showing symptoms on September 3, 2012 - he had traveled to Saudi Arabia before the start of his illness. The individual was treated in the intensive care unit (ICU) in Doha, Qatar on September 7 and then transferred to the UK by air ambulance on September 11. This particular man is the second identified with this novel coronavirus. The first patient, from Saudi Arabia, has since died. The Health Protection Agency of the HPA (UK) has completed laboratory testing and has confirmed the existence of a novel coronavirus characterized by acute respiratory syndrome. Symptoms include: fever, cough, shortness of breath, and breathing difficulties. The HPA has compared the pattern of the virus distinguished from the 49 year-old Qatari national with that of a virus sequenced earlier by the Erasmus University Medical Center, Netherlands. The latter virus was obtained from lung tissue of a different fatal case earlier this year in a 60 year-old Saudi national. This comparison suggested a 99.5 percent match with just one nucleotide mismatch over the regions compared. Coronaviruses are a family of viruses that include viruses that cause SARS and the common cold. This is an unfamiliar novel coronavirus, different from others previously identified in humans. The two confirmed cases have experienced a serious respiratory illness, making it similar to SARS but not identical.
A new study has found that even though HIV diversifies widely within infected individuals over time, the virus strains that ultimately are passed on through heterosexual transmission often resemble the strain of virus that originally infected the transmitting partner. Learning the characteristics of these preferentially transmitted HIV strains may help advance HIV prevention efforts, particularly with regard to an HIV vaccine, according to the scientists who conducted the study. The research was led by Andrew D. Redd, Ph.D., staff scientist, and Thomas C. Quinn, M.D., senior investigator, both in the Laboratory of Immunoregulation of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Dr. Redd and colleagues examined particular genetic sequences of HIV in blood samples collected between 1994 and 2002 from hundreds of HIV-infected heterosexuals participating in the Rakai Community Cohort Study in Rakai District, Uganda. The scientists found a significant increase in population-wide HIV genetic diversity among infected individuals during the 8-year period, yet the amount of genetic change was significantly greater within individuals than across the population as a whole. To explain this phenomenon, the scientists hypothesized that the genetic diversity of HIV at the population level was limited because only certain strains of the virus within each person were responsible for subsequent sexual transmissions to test this hypothesis, the scientists examined the genetic relatedness of HIV strains in 31 couples where heterosexual transmission occurred. Through three increasingly comprehensive analyses, they compared HIV strains in the transmitting partner at points before and around the estimated time of HIV transmission with the strain in the newly infected partner around the time of transmission. In 22 of the couples, or 71 percent of those studied, the virus strains in the blood of the newly infected partner were more closely related to those found in the blood of the transmitting partner at the earliest available time point than to strains present around the time of transmission. According to Dr. Redd, this finding demonstrates that in the heterosexual transmission of HIV, the frequent natural selection of viral strains from early in the infection of the transmitting partner reduces viral diversity at the population level. Moreover, in four couples, the newly acquired strain was highly similar or identical to specific variants found in the transmitting partner at both the earliest time point and the time of transmission. The scientists hypothesize that these highly transmissible HIV strains from early infection were sustained in the blood at low levels or sequestered in certain cells for transmission at a later time. Related research by other scientists shows that HIV strains found in infected individuals during the early stages of infection have diversified little from the strain that caused infection. Thus, the fact that these early HIV strains somehow are maintained or persist at low levels for transmission later suggests they may have an evolutionary advantage at crossing the genital barrier and causing infection, compared with HIV strains that predominate later in infection, according to Dr. Redd.